Medical Properties Trust, Inc. (NYSE:MPW) stock is currently pricing at roughly $13.08. Our analysis shows that the stock is widely covered by equity research firms, and target prices are revealing. From a summary standpoint, we track the median one-year price target among 11 analysts covering the company at $14.00. That suggests shares of the stock may have another 7 percent to the upside left to run. Of those analysts we surveyed, the highest price target on recordsits at $16.00, which would imply another 78 percent in upside potential. If we look for a little more qualitative data on the range of expectations, we find in analyst notes that the stock has 3 “Buy” ratings in place. At the same time, 2 rate the stock a “strong buy”, suggesting more conviction in the story. As for the doubters, 7 equity research analyst firms call this stock a “Hold” and 1 consider it bad enough to warrant a “Sell” rating.

Analysts at Jefferies took a look at MPW shares in a research note released on Apr 07, 2017, and issued a Buy rating to this company. Robert W. Baird analysts provided their own take on company recently as well. In a research note published on Mar 10, 2017,the house assigned a Outperform rating to this stock. According to a piece that hit the wires on Dec 13, 2016, researchers at Wells Fargo reconsidered their prior rating on the stock, and lowered it from Market Perform Perform to Underperform.

Medical Properties Trust, Inc. (MPW) Cap Table Analysis

Breaking down the capitalization table is our next goal. From a bird’s eye view, Executives hold 1.52 percent of the stock.

If we take a more granular look, Edward K. Aldag,Jr is one of the largest owners in company capital stock among insiders. According to U.S. Securities and Exchange Commission (SEC) filings, this investor owns 2,286,213 shares, representing a total current market value of roughly $29903666.04. R. Steven Hamner is another major player among company insiders, currently holding 1,095,845 shares as of 0.34%, carrying a current market value of $14333652.6. Emmett E. Mclean is currently ranked as the number three insider in terms of representation on the cap table for the stock, holding 867,169 shares, valued at around $11342570.52 as of recent close.

We noted a few insider transactions for the stock recently as well.

In a transaction on 2017-03-28, the company’s Chairman, President & CEO Aldag Edward K JR sold 301,845 company shares for 3845510. That means, once accounting for this transaction, the Chairman, President & CEO is left with a stake of 1,734,368 shares, carrying a current total market value of $22685533. In addition, by means of a transaction dated 2017-03-08, Director McKenzie William G sold 41,270 shares worth $514220. After that transaction, this investor is left with a total holding of 42,189 shares, representing a total investment value of $551832.12. We also noted a 2017-01-04 transaction in which MPW VP, Controller, and CAO Hanna James Kevin sold 10,000 shares at a stock price of $12.57, carrying a total value of $125700, after which, this insider’s investment stands at 87,343 shares, with an overall financial value of $1142446.

Medical Properties Trust, Inc. (NYSE:MPW) Earnings View 

In the company’s last quarter, MPW EPS moved to $0.31 from $0.30 compared sequentially with the prior quarter. Revenues for the company came in at $153.28MM. This stacks up against $126.56MM, on a sequential basis.

How does this compare with bottom and top-line expectations? Well, according to what we could find, analysts had been looking for the company to post net income of about $0.30 per share on $151.13MM in revenue. That sets up an interesting next quarter report card. We would note that analysts seem to be projecting earnings, on average, for this quarter in the range of $0.31 to $0.35. On a year-over-year basis, that compares with an EPS comp of $0.35.